NEW DELHI: Ranbaxy Laboratories Ltd said on Friday that it anticipates a loss of $150 million on sales of $1.4 billion in the year ending December
2009. Ranbaxy, in which Japan's Daiichi Sankyo owns about 64 percent, had posted a net loss of $187 million in 2008.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment